Your Notifications
All done, no notifications
Dr. Prof. Oreste Gentilini

Dr. Prof. Oreste Gentilini

Breast Surgeon ·
, milan, Italy

27+ of experience ·
Languages Spoken: English, Italian

Book a video consultation with Prof. Oreste Gentilini for Breast Surgeon, from USD 503. Receive a signed report within 24 hours or a full refund if unavailable.
USD 503per video consult
Book & Pay – USD 503Chat on WhatsApp Free 15-min Screening

Specialises in:

Early-stage breast cancerInvasive breast cancerBreast cancer requiring breast-conserving surgeryBreast cancer requiring mastectomyBreast cancer requiring sentinel lymph node biopsy

About Dr. Prof. Oreste Gentilini

  • Prof. Oreste Davide Gentilini is a specialist in breast surgery and the surgical management of breast cancer.
  • He has served as Head of the Breast Surgery Unit and Director of the Breast Unit at IRCCS Ospedale San Raffaele in Milan, Italy, since 2015, according to the supplied biography.
  • He is an Associate Professor of General Surgery at Vita-Salute San Raffaele University in Milan.
  • He also collaborates with Casa di Cura La Madonnina and Policlinico San Marco in Bergamo.
  • He has devoted his clinical and research career to breast cancer since 2001, following a research fellowship at New York Hospital–Cornell Medical Center in the United States.
  • He previously worked at the European Institute of Oncology from 2000 to 2015, eventually becoming Senior Vice Director of the Breast Division.
  • His clinical interests include breast-conserving surgery, sentinel lymph node biopsy, axillary lymph node management, and oncoplastic breast surgery.
  • He has expertise in familial and hereditary breast cancer and risk-reducing surgical procedures for women with a high genetic risk of developing breast cancer.
  • He has personally performed more than 5,000 breast surgery procedures, according to the supplied biography.
  • He coordinated and served as principal investigator of the international multicentre SOUND trial, which investigated axillary staging strategies in women with early breast cancer.
  • He is a founding member and president of EUBREAST, an international breast cancer research organization, according to the supplied biography.
  • He has authored more than 100 international publications and has been invited to speak at numerous national and international scientific conferences.

Conditions treated by Prof. Oreste GENTILINI

  • Early-stage breast cancer
  • Invasive breast cancer
  • Breast cancer requiring breast-conserving surgery
  • Breast cancer requiring mastectomy
  • Breast cancer requiring sentinel lymph node biopsy
  • Breast cancer involving the axillary lymph nodes
  • Breast cancer requiring assessment of axillary lymph node involvement after neoadjuvant treatment
  • Familial breast cancer
  • Hereditary breast cancer

Area of Interest

  • Breast surgical oncology
  • Breast-conserving surgery
  • Mastectomy and nipple-sparing mastectomy in selected patients
  • Oncoplastic breast surgery
  • Sentinel lymph node biopsy
  • Axillary lymph node staging and management
  • Reducing the extent of axillary surgery in appropriately selected patients
  • Surgical management following neoadjuvant chemotherapy
  • Familial and hereditary breast cancer
  • Risk-reducing breast surgery for women at high genetic risk
  • Breast cancer in young women
  • Breast cancer during pregnancy

Qualification

  • Degree in Medicine and Surgery – University of Milan, Italy, 1993, with honors
  • Specialization in General Surgery – University of Milan, Italy, 1999, with honors

Work Experiences

  • Head of the Breast Surgery Unit - IRCCS Ospedale San Raffaele, Milan, Italy, since 2015, according to the supplied biography
  • Director of the Breast Unit - IRCCS Ospedale San Raffaele, Milan, Italy, since 2015, according to the supplied biography
  • Associate Professor of General Surgery - Vita-Salute San Raffaele University, Milan, Italy
  • Senior Vice Director of the Breast Division - European Institute of Oncology, Milan, Italy, before 2015
  • Clinical and Research Professional - European Institute of Oncology, Milan, Italy, 2000–2015
  • Research Fellow - New York Hospital–Cornell Medical Center, United States
  • Clinical Collaborator - Casa di Cura La Madonnina, Italy
  • Clinical Collaborator - Policlinico San Marco, Bergamo, Italy
  • Tenured Lecturer - Medicine and Surgery degree programs, International MD Program, School of Specialization in General Surgery, and Midwifery degree program at Vita-Salute San Raffaele University

Certifications (1)

  • Research Fellowship - New York Hospital-Cornell Medical Center, United States.

Memberships (4)

  • EUBREAST (European Breast Cancer Research Association of Surgical Trialists) - Founding member and president, according to the supplied biography
  • EU-BREAST - Founding member, board member, and vice president since 2018, as described in the biography
  • ANISC (Italian National Association of Breast Surgeons) - Board member since 2019
  • European expert panel on breast cancer in young women and during pregnancy - Member since 2012

Ready to Speak with Prof. Oreste Gentilini?

Book a secure video consultation for expert General Surgeon care.

Book Consultation

What to Expect in Your Consultation

Upload Your Medical Reports

Upload MRI/CT scans, laboratory reports, prescriptions, and previous medical records. Supported formats: PDF, JPEG, and DICOM.

30-Min Video Consultation

Consult the Doctor in your preferred language. A family member or caregiver is welcome to join.

Medical Opinion Within 24 Hours

Receive a signed medical opinion with diagnosis, treatment recommendations, and next steps in a downloadable PDF.

Care Coordination (Optional)

If needed, our team can assist with a second opinion, hospital appointments, or medical travel arrangements.

Procedures Performed

Lumpectomy
Mastectomy

Frequently Asked Questions

Prof. Oreste GENTILINI is available to teleconsult on the MediGence platform.

The consultation typically lasts between 15 and 30 minutes. It may exceed the estimated time, depending on the patient’s questions and the doctor's medical recommendations.

We have Medical specialists and board-certified doctors on our panel. The consultation will be organised within 24 to 48 hours, or based on the availability of the doctor and the patient.

No, the follow-up consultation fee is not included in the consultation price. The patient will be required to re-book the consultation.

The option to share your medical records is available between steps in the form provided on the website.

Yes. If you are satisfied with the consultation, you can proceed with treatment packages tailored to your diagnosis, with assistance from our case managers.

Yes. The cost estimate will be provided to you by our case manager, including the doctor’s opinion, the cost estimate, and crucial information about travelling to your medical destination.

FAQ's Related to General surgeon

A breast surgeon evaluates and surgically treats breast conditions, including breast cancer. Depending on the diagnosis, treatment may involve breast-conserving surgery, mastectomy, sentinel lymph node biopsy, or other procedures. The recommended approach depends on the tumour, disease stage, and patient's preferences.

Breast-conserving surgery removes the cancer and a surrounding margin of healthy tissue while preserving most of the breast. It is often followed by radiotherapy, although the overall treatment plan depends on the patient's clinical circumstances. It is not suitable for every breast cancer.

Treatment may be possible during pregnancy, but options depend on the stage of pregnancy, cancer subtype, disease extent, and the patient's needs. Care requires coordination between breast oncology, surgery, medical oncology, obstetrics, and other specialists. Some treatments are avoided during pregnancy, so individualised planning is essential.

Neither approach is universally better for every patient. For appropriately selected patients, breast-conserving surgery followed by radiotherapy can provide survival outcomes comparable to mastectomy. The choice depends on the cancer's characteristics, whether clear margins can be achieved, genetic risk, previous treatment, and patient preferences.

Yes. Surgery is commonly performed after neoadjuvant systemic treatment when this is part of the treatment plan. The operation is planned based on the tumour's response, residual disease, lymph node findings, and other clinical factors.

A multidisciplinary team may include breast surgeons, medical oncologists, radiation oncologists, radiologists, pathologists, genetic specialists, and reconstructive surgeons. Collaboration helps coordinate diagnosis and treatment and supports decisions that reflect the cancer's characteristics and the patient's priorities.

Explore Telemedicine Specialists

Please Enquire

Required | alphabets and spaces
Required | A valid, working email address
Required | A valid contact

Not Sure About Your Treatment Plan? Get a Second Opinion

Get your medical reports reviewed by experienced doctors to help you make a confident treatment decision, all online within 48 hours.